BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 28219222)

  • 1. IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia.
    Schmugge M; Franzoso FD; Winkler J; Kroiss S; Seiler M; Speer O; Rand ML
    Br J Haematol; 2023 Jun; 201(6):1209-1219. PubMed ID: 36861460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation.
    Ponomarenko EA; Ignatova AA; Polokhov DM; Filkova AA; Suntsova EV; Zharkov PA; Fedorova DV; Pisaryuk AS; Meray I; Kobalava ZD; Tukhsanboev YS; Maschan AA; Novichkova GA; Sveshnikova AN; Panteleev MA
    Eur J Haematol; 2024 Apr; 112(4):554-565. PubMed ID: 38083800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-specific antibodies and differences in their expression in childhood immune thrombocytopenic purpura predicts clinical progression.
    Fu L; Ma J; Cheng Z; Gu H; Ma J; Wu R
    Pediatr Investig; 2018 Dec; 2(4):230-235. PubMed ID: 32851271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients.
    Zhang Y; Liu F; Liang X; Zhu J; Han L; Shi X; Cao J; Li Z; Chen W; Xu K; Cheng H
    Clin Exp Med; 2023 Dec; 23(8):4483-4491. PubMed ID: 36976377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment Absolute Immature Platelet Count is a Promising Predictor of Response to Short-Term Dexamethasone Monotherapy or Combination Therapy in Newly Diagnosed Adult Primary Immune Thrombocytopenia.
    Lv M; Xu Q; Ye X; Yu Q; Wang B; Wang Y
    Indian J Hematol Blood Transfus; 2024 Apr; 40(2):289-296. PubMed ID: 38708160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic corpus luteum hemorrhage in adolescent females with ITP.
    Yelak A; From A; Gilad O; Brik Simon D; Rubin S; Cohen M; Amarilyo G; Levin C; Bakry D; Izraeli S; Tamary H; Yacobovich J; Steinberg-Shemer O
    Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38602530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding self-assessments by patients with immune thrombocytopenia (ITP): An agreement study.
    Clerici B; Masood S; Nazy I; Tang N; Cranstone M; Liu Y; Hadzi-Tosev M; Nixon J; St John M; Shirinzadeh M; Jamula E; Kelton JG; Arnold DM
    Am J Hematol; 2024 Jun; 99(6):1184-1186. PubMed ID: 38534202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?
    Rabbolini DJ; Gardiner EE; Morel-Kopp MC; Dunkley S; Jahangiri A; Lee CS; Stevenson WS; Ward CM
    Res Pract Thromb Haemost; 2017 Oct; 1(2):291-295. PubMed ID: 30046699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia.
    Zhou J; Zhou Y; Wen J; Sun X; Zhang X
    Braz J Med Biol Res; 2017 Feb; 50(2):e5637. PubMed ID: 28225866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Integrin α
    Martyanov AA; Morozova DS; Sorokina MA; Filkova AA; Fedorova DV; Uzueva SS; Suntsova EV; Novichkova GA; Zharkov PA; Panteleev MA; Sveshnikova AAN
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.
    Psaila B; Bussel JB; Frelinger AL; Babula B; Linden MD; Li Y; Barnard MR; Tate C; Feldman EJ; Michelson AD
    J Thromb Haemost; 2011 Nov; 9(11):2302-10. PubMed ID: 21920014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?
    Boulware R; Refaai MA
    Thromb Res; 2020 Mar; 187():154-158. PubMed ID: 32004875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relative analysis of platelet activation with bleeding risk in patients with primary immune thrombocytopenia].
    Lyu ME; Li Y; Lyu CC; Liu WJ; Guan Y; Wang SX; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):33-38. PubMed ID: 28219222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Predictive Effect of Platelet Activation Index Expression before and after Adenosine Bisphosphate Activation on Bleeding Risk in ITP Patients].
    Qiu HC; Liu Q; Kong R; Wu PF; Zhang XL; Wu DH; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1236-1240. PubMed ID: 31418386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.
    Frelinger AL; Grace RF; Gerrits AJ; Berny-Lang MA; Brown T; Carmichael SL; Neufeld EJ; Michelson AD
    Blood; 2015 Aug; 126(7):873-9. PubMed ID: 26138687
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.